Kintor Pharmaceutical Limited (HKG:9939)
Hong Kong · Delayed Price · Currency is HKD 1.910
-0.010 (-0.52%)
Jul 10, 2026, 1:23 PM HKT
Kintor Pharmaceutical Market Cap
Kintor Pharmaceutical has a market cap or net worth of 948.11 million as of July 9, 2026. Its market cap has increased by 36.47% in one year.
Market Cap
948.11M
Enterprise Value
1.01B
Revenue
36.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.91
Market Cap Chart
Since May 22, 2020, Kintor Pharmaceutical's market cap has decreased from 7.94B to 948.11M, a decrease of -88.06%. That is a compound annual growth rate of -29.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 948.11M | -1.98% |
| Dec 31, 2025 | 967.31M | 130.32% |
| Dec 31, 2024 | 419.98M | -42.42% |
| Dec 29, 2023 | 729.42M | -83.45% |
| Dec 30, 2022 | 4.41B | -7.54% |
| Dec 31, 2021 | 4.77B | 23.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HighTide Therapeutics | 1.50B |
| Zhaoke Ophthalmology | 1.43B |
| Beijing Biostar Pharmaceuticals | 1.34B |
| CANbridge Pharmaceuticals | 1.29B |
| Cloudbreak Pharma | 1.01B |
| Sunho Biologics | 970.43M |
| Cutia Therapeutics | 962.93M |
| Shanghai Bio-heart Biological Technology | 788.67M |